Science Explorer Interactive view Map

HemoGenix (United States)

Research works
19
▼ 100% vs 2013–17
Citations
171
8.9 per fractional work
Top-10% rate
0.0%
record average 16.5%
Open access
28%
world 28%

Not ranked overall: HemoGenix (United States) is under the volume floor below which an excellence rate is noise. Not ranked is not the same as ranked last.

Field profile

Location quotient across every field it publishes in: outside the ring is more than an institution of this size would be expected to publish, inside it is less.

Which research topics does HemoGenix (United States) publish most on?

By volume in 2022–2025: Cell Adhesion Molecules Research, Corneal Surgery and Treatments, Reproductive System and Pregnancy and Tissue Engineering and Regenerative Medicine.

  1. 1 Cell Adhesion Molecules Research Immunology and Allergy 0 works
  2. 2 Corneal Surgery and Treatments Radiology, Nuclear Medicine and Imaging 0 works
  3. 3 Reproductive System and Pregnancy Immunology 0 works
  4. 4 Tissue Engineering and Regenerative Medicine Surgery 0 works
  5. 5 Mesenchymal stem cell research Genetics 0 works
  6. 6 Pluripotent Stem Cells Research Molecular Biology 0 works

How open and international is its research?

Against the world’s own shares — the tick on each track. Both are shares of its output, so they sit on one scale and can be read against each other as well as against the world.

openly available27.5%not open72.5%

World: 28% of research is openly available.

with international co-authors3.2%domestic only96.8%

World: 19% is written across borders.

How has HemoGenix (United States)'s research output changed?

Output in 2018–2022 was 100% lower than in 2013–2017.

2005201020152020
grewheldshrank

The same series as a ribbon — one cell per year, darker for more. The line above answers how much; this answers when.

Other research institutions in Colorado Springs

All research institutions in Colorado Springs

Research measures only: rankings here say nothing about teaching, admissions or student experience. Comparable institutions and collaboration partners are in the interactive view on the map.